0001179110-15-007533.txt : 20150511
0001179110-15-007533.hdr.sgml : 20150511
20150511170318
ACCESSION NUMBER: 0001179110-15-007533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150507
FILED AS OF DATE: 20150511
DATE AS OF CHANGE: 20150511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABIOMED INC
CENTRAL INDEX KEY: 0000815094
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042743260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 22 CHERRY HILL DR
CITY: DANVERS
STATE: MA
ZIP: 01923
BUSINESS PHONE: 9787775410
MAIL ADDRESS:
STREET 1: 22 CHERRY HILL DRIVE
CITY: DANVERS
STATE: MA
ZIP: 01923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howley Michael G
CENTRAL INDEX KEY: 0001456804
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09585
FILM NUMBER: 15851641
MAIL ADDRESS:
STREET 1: 22 CHERRY HILL DRIVE
CITY: DANVERS
STATE: MA
ZIP: 01923
4
1
edgar.xml
FORM 4 -
X0306
4
2015-05-07
0
0000815094
ABIOMED INC
ABMD
0001456804
Howley Michael G
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE
DANVERS
MA
01923
0
1
0
0
VP, Global Sales & Marketing
Common Stock, $.01 par value
2015-05-07
4
M
0
10699
5.23
A
96282
D
Common Stock, $.01 par value
2015-05-07
4
S
0
9900
69.9971
D
86382
D
Common Stock, $.01 par value
2015-05-07
4
S
0
1528
70.8092
D
84854
D
Common Stock, $.01 par value
2015-05-07
4
S
0
986
71.8516
D
83868
D
Common Stock, $.01 par value
2015-05-07
4
S
0
484
73.0029
D
83384
D
Common Stock, $.01 par value
2015-05-07
4
S
0
84
73.7762
D
83300
D
Stock Option (Right to Buy)
5.23
2015-05-07
4
M
0
10699
0
D
2009-03-05
2019-03-05
Common Stock
10699
14301
D
Stock Option (right to buy)
10.03
2011-06-03
2020-06-03
Common Stock
0
30000
D
Stock Option (Right to buy)
22.44
2013-05-22
2022-05-22
Common Stock
0
25000
D
Stock Option (Right to Buy)
23.15
2014-05-14
2023-05-14
Common Stock
0
25000
D
Stock Option (Right to Buy)
21.55
2015-05-14
2024-05-14
Common Stock
0
25000
D
Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Sale of common stock pursuant to reporting owner's 10b5-1 plan.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.5000 and $70.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.5000 and $71.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.5200 and $72.3900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.5300 and $73.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $73.5300 and $73.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
/s/ Stephen C. McEvoy (by power of attorney)
2015-05-11
EX-24
2
ex24howley.txt
LIMITED POWER OF ATTORNEY
The undersigned does hereby appoint each of
Stephen McEvoy, Ian McLeod and Loretta Wedge, signing singly,
the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the
undersigned, in the undersigned's capacity as a
director or officer of ABIOMED, Inc. (the "Company"),
Forms 3, 4 and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934 and the rules
thereunder;
(2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary or
desirable to complete and execute any such Form 3, 4
or 5 and timely file such form with the United States
Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever
in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the
undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall
be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-
fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and
powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are
not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required
to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in
securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, this power of attorney has
been executed as of the 19th day of February, 2009 and
shall remain in full force and effect until withdrawn
by the undersigned in writing.
Signature:
/s/ Michael G. Howley
Print Name: Michael G. Howley